Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Squamous cell carcinoma of the head and neck
0.080 Biomarker disease BEFREE eIF4E and 4EBP1 are prognostic markers of head and neck squamous cell carcinoma recurrence after definitive surgery and adjuvant radiotherapy. 31756179 2019
Squamous cell carcinoma of the head and neck
0.080 Biomarker disease BEFREE Because 4EBP1 modulates eIF4E activity, our results highlight the importance of incorporating a joint analysis of eIF4E and 4EBP1 mRNAs in HNSCC patient care decisions. 21898433 2011
Squamous cell carcinoma of the head and neck
0.080 AlteredExpression disease BEFREE Overexpression of eIF4E in histologically "tumor-free" surgical margins of head and neck squamous cell cancer (HNSCC) patients is an independent predictor of recurrence and is functionally activated through the Akt/mammalian target of rapamycin (mTOR) pathway. 17332346 2007
Squamous cell carcinoma of the head and neck
0.080 Biomarker disease BEFREE eIF4E (4E) is elevated in 100% of head and neck squamous cell carcinoma (HNSCC) and in premalignant lesions of the larynx. 11956537 2002
Squamous cell carcinoma of the head and neck
0.080 Biomarker disease BEFREE To date, the proto-oncogene eIF4E (4E) is elevated in 100% of head and neck squamous cell carcinoma tumors and is of prognostic value in predicting recurrence. 12461330 2002
Squamous cell carcinoma of the head and neck
0.080 Biomarker disease BEFREE Antisense RNA to eIF4E suppresses oncogenic properties of a head and neck squamous cell carcinoma cell line. 10852506 2000
Squamous cell carcinoma of the head and neck
0.080 Biomarker disease BEFREE All 18 HNSCC specimens tested had significant eIF4E gene amplification (4.3+/-1.2; P < .05). 10077200 1999
Squamous cell carcinoma of the head and neck
0.080 Biomarker disease BEFREE The eIF4E gene was amplified in the tumor core of both IDCA (3.8 +/- 1.4, P < 0.05, Student's t test) and HNSCC (4.3 +/- 1.4, P < 0.05) specimens. 10383835 1999